Back

Impact of atrial fibrillation type on outcomes following aerobic exercise training: analysis from the ACTIVE-AF Trial

28 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Metabolic risk, exercise, and heart disease Exercise ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Adrian Elliott

University of Adelaide, Adelaide (Australia)

7 More presentations in this session

Presentation thumbnail
Association of physical activity intensity with cardiovascular disease and mortality in high-income, middle-income and low-income countries: the PURE study
Doctor S. Lear (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Sex-specific associations of the difference between 2-hour post-load and fasting plasma glucose with cardiovascular risk in a normoglycemic population
Doctor A. Abdi (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Effect of exercise training on cardiorespiratory fitness, quality of life and objectively measured physical activity in patients undergoing anthracycline-based chemotherapy: the Caprice RCT
Ms L. Stuetz (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Lower cardiorespiratory fitness is associated with left atrial structural, functional and electrical remodelling in patients with symptomatic atrial fibrillation
Doctor A. Elliott (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Circulating hexose-derived metabolites are biomarker candidates for diabetes risk prediction
Doctor C. Schulte (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic risk, exercise, and heart disease

The Event

Event poster

ESC Congress 2023

28 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Secondary prevention and rehabilitation
thumbnail
Congress Presentation
Which exercise is possible with hypertensive heart disease?
thumbnail
Congress Presentation
Evidence-based lifestyle interventions for cardiovascular prevention in obesity

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources